SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056269
Filing Date
2021-11-10
Accepted
2021-11-10 17:00:51
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20210930.htm   iXBRL 10-Q 1272466
2 EX-31.1 odt-ex311_7.htm EX-31.1 18264
3 EX-31.2 odt-ex312_8.htm EX-31.2 18346
4 EX-32.1 odt-ex321_6.htm EX-32.1 15865
  Complete submission text file 0001564590-21-056269.txt   4391216

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA odt-20210930.xsd EX-101.SCH 33520
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20210930_cal.xml EX-101.CAL 30783
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20210930_def.xml EX-101.DEF 74400
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20210930_lab.xml EX-101.LAB 265542
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20210930_pre.xml EX-101.PRE 191095
10 EXTRACTED XBRL INSTANCE DOCUMENT odt-10q_20210930_htm.xml XML 669808
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 211397629
SIC: 2834 Pharmaceutical Preparations